Can biopharma police itself? Who decides whether something's a disease or a difference? And will fecal matter ever become a drug?

Episode 100: Wall Street's coronavirus freakout, clinical trial difficulties, and a look back

STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.